LINC01225
Unveiling the Role of LINC01225: A Promising Biomarker and Therapeutic Target
Description
LINC01225, also known as long intergenic non-protein coding RNA 1225, is a recently discovered non-coding RNA molecule that has garnered significant interest in the research community. It plays a crucial role in various cellular processes, influencing gene expression and modulating biological functions.
Associated Diseases
Aberrant expression of LINC01225 has been linked to several diseases, including:
-
Cancers: LINC01225 is upregulated in many cancer types, such as breast, lung, and colorectal cancer. It promotes cancer cell proliferation, migration, and invasiveness.
-
Neurodegenerative disorders: LINC01225 dysregulation has been implicated in Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis (ALS). It contributes to neuronal damage and cognitive impairment.
-
Cardiovascular diseases: LINC01225 expression is altered in heart failure and myocardial infarction. It affects cardiac remodeling and inflammation.
-
Diabetes: LINC01225 is involved in insulin resistance and glucose intolerance in type 2 diabetes.
Did you Know ?
According to recent research, elevated LINC01225 expression is found in over 70% of breast cancer patients. This high prevalence underscores its potential as a diagnostic and prognostic biomarker.
